Semmelweis Publications
  • Main page

    • Center for Health Technology Assessment - Publications (article, review) indexed in international databases (2020-2025)

    Year:
    Order by:
    SU Authorship:
    Number of publications: 139
    1.
    GraphCPP: The new state-of-the-art method for cell-penetrating peptide prediction via graph neural networks
    Imre, A;Balogh, B;Mándity, I
    D1
    BRITISH JOURNAL OF PHARMACOLOGY
    2024.
    DOI:10.1111/bph.17388 (Copy DOI)
    2.
    Multistakeholder Perceptions of Additional Value Elements for United States Value Assessment of Health Interventions
    McQueen, RB;Inotai, A;Zemplenyi, A;Mendola, N;Németh, B;Kalo, Z
    D1
    VALUE IN HEALTH
    2024.
    DOI:10.1016/j.jval.2023.09.2910 (Copy DOI)
    3.
    Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary-the HUN-VE study
    Vokó, Z;Kiss, Z;Surján, G;Surján, O;Barcza, Z;Pályi, B;Formanek-Balku, E;Molnár, GA;Herczeg, R;Gyenesei, A;Miseta, A;Kollár, L;Wittmann, I;Müller, C;Kásler, M
    D1
    CLINICAL MICROBIOLOGY AND INFECTION
    2022.
    DOI:10.1016/j.cmi.2021.11.011 (Copy DOI)
    4.
    The effect of social distance measures on COVID-19 epidemics in Europe: an interrupted time series analysis
    Vokó, Z;Pitter, JG
    D1
    GEROSCIENCE
    2020.
    DOI:10.1007/s11357-020-00205-0 (Copy DOI)
    5.
    Frailty prevalence in 42 European countries by age and gender: development of the SHARE Frailty Atlas for Europe
    Pitter, JG;Zemplényi, A;Babarczy, B;Németh, B;Kaló, Z;Vokó, Z
    D1
    GEROSCIENCE
    2024.
    DOI:10.1007/s11357-023-00975-3 (Copy DOI)
    6.
    Effectiveness of educational interventions for healthcare workers on vaccination dialogue with older adults: a systematic review
    Wennekes, MD;Almási, T;Eilers, R;Mezei, F;Petykó, ZI;Timen, A;Vokó, Z
    Q1
    ARCHIVES OF PUBLIC HEALTH
    2024.
    DOI:10.1186/s13690-024-01260-1 (Copy DOI)
    7.
    Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary
    Merkely, B;Szabo, AJ;Kosztin, A;Berenyi, E;Sebestyen, A;Lengyel, C;Merkely, G;Karady, J;Varkonyi, I;Papp, C;Miseta, A;Betlehem, J;Burian, K;Csoka, I;Vásárhelyi, B;Ludwig, E;Prinz, G;Sinko, J;Hanko, B;Varga, P;Fulop, GA;Mag, K;Voko, Z
    D1
    GEROSCIENCE
    2020.
    DOI:10.1007/s11357-020-00226-9 (Copy DOI)
    Semmelweis University authors: Merkely, Béla Péter, Szabó, Attila, Kosztin, Annamária, Merkely, Gergő, Karády, Júlia, Vásárhelyi, Barna, Sinkó, János, Hankó, Balázs, Varga, Péter, Fülöp, Gábor Áron, Vokó, Zoltán, Gajdácsi, József, Kristóf, Katalin, Boros, Kriszta Katinka, Oroszi, Beatrix,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Department of Laboratory Medicine, Department of Pediatrics, Orvosi Képalkotó Klinika, Department of Cardiology – Heart and Vascular Center, Cardiovascular Center, Faculty of Sports Medicine, Faculty of Pharmacy, University Pharmacy Department of Pharmacy Administration, Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket), Center for Health Technology Assessment, Center of Epidemiology and Survaillance, I. Department of Pediatrics,
    8.
    Effectiveness of SARS-CoV-2 primary vaccines and boosters in patients with type 2 diabetes mellitus in Hungary (HUN-VE 4 Study)
    Molnár, GA;Vokó, Z;Süto, G;Rokszin, G;Nagy, D;Surján, G;Surján, O;Nagy, P;Kenessey, I;Wéber, A;Pálosi, M;Müller, C;Kásler, M;Wittmann, I;Kiss, Z
    Q1
    BMJ OPEN DIABETES RESEARCH & CARE
    2024.
    DOI:10.1136/bmjdrc-2023-003777 (Copy DOI)
    9.
    Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review
    Fasseeh, AN;Elezbawy, B;Korra, N;Tannira, M;Dalle, H;Aderian, S;Abaza, S;Kaló, Z
    D1
    DERMATOLOGY AND THERAPY
    2022.
    DOI:10.1007/s13555-022-00819-6 (Copy DOI)
    10.
    Cardioprotective efficacy of limb remote ischaemic preconditioning in rats: discrepancy between a meta-analysis and a three-centre in vivo study
    Sayour, NV;Brenner, GB;Makkos, A;Kiss, B;Kovácsházi, C;Gergely, TG;Aukrust, SG;Tian, HM;Zenkl, V;Gömöri, K;Szabados, T;Bencsik, P;Heinen, A;Schulz, R;Baxter, GF;Zuurbier, CJ;Vokó, Z;Ferdinandy, P;Giricz, Z
    D1
    CARDIOVASCULAR RESEARCH
    2023.
    DOI:10.1093/cvr/cvad024 (Copy DOI)
    11.
    The Burden of Obesity in Egypt
    Aboulghate, M;Elaghoury, A;Elebrashy, I;Elkafrawy, N;Elshishiney, G;Abul-Magd, E;Bassiouny, E;Toaima, D;Elezbawy, B;Fasseeh, A;Abaza, S;Vokó, Z
    Q1
    FRONTIERS IN PUBLIC HEALTH
    2021.
    DOI:10.3389/fpubh.2021.718978 (Copy DOI)
    12.
    Framework for developing cost-effectiveness analysis threshold: the case of Egypt
    Fasseeh, AN;Korra, N;Elezbawy, B;Sedrak, AS;Gamal, M;Eldessouki, R;Eldebeiky, M;George, M;Seyam, A;Abourawash, A;Khalifa, AY;Shaheen, M;Abaza, S;Kalo, Z
    Q1
    JOURNAL OF THE EGYPTIAN PUBLIC HEALTH ASSOCIATION
    2024.
    DOI:10.1186/s42506-024-00159-7 (Copy DOI)
    13.
    Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment
    Zemplényi, A;Tachkov, K;Balkanyi, L;Németh, B;Petykó, ZI;Petrova, G;Czech, M;Dawoud, D;Goettsch, W;Ibarluzea, IG;Hren, R;Knies, S;Lorenzovici, L;Maravic, Z;Piniazhko, O;Savova, A;Manova, M;Tesar, T;Zerovnik, S;Kaló, Z
    Q1
    FRONTIERS IN PUBLIC HEALTH
    2023.
    DOI:10.3389/fpubh.2023.1088121 (Copy DOI)
    14.
    Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study)
    Voko, Z;Kiss, Z;Surjan, G;Surjan, O;Barcza, Z;Wittmann, I;Molnar, GA;Nagy, D;Muller, V;Bogos, K;Nagy, P;Kenessey, I;Weber, A;Polivka, L;Palosi, M;Szlavik, J;Rokszin, G;Muller, C;Szekanecz, Z;Kasler, M
    Q1
    FRONTIERS IN IMMUNOLOGY
    2022.
    DOI:10.3389/fimmu.2022.919408 (Copy DOI)
    15.
    Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status
    Fasseeh, A;Karam, R;Jameleddine, M;George, M;Kristensen, FB;Al-Rabayah, AA;Alsaggabi, AH;El Rabbat, M;Alowayesh, MS;Chamova, J;Ismail, A;Abaza, S;Kaló, Z
    Q1
    FRONTIERS IN PHARMACOLOGY
    2020.
    DOI:10.3389/fphar.2020.00015 (Copy DOI)
    16.
    Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study)
    Kiss, Z;Wittmann, I;Polivka, L;Surjan, G;Surjan, O;Barcza, Z;Molnar, GA;Nagy, D;Mueller, V;Bogos, K;Nagy, P;Kenessey, I;Weber, A;Palosi, M;Szlavik, J;Schaff, Z;Szekanecz, Z;Mueller, C;Kasler, M;Voko, Z
    Q1
    FRONTIERS IN IMMUNOLOGY
    2022.
    DOI:10.3389/fimmu.2022.905585 (Copy DOI)
    17.
    Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries
    Tachkov, K;Zemplenyi, A;Kamusheva, M;Dimitrova, M;Siirtola, P;Ponten, J;Nemeth, B;Kalo, Z;Petrova, G
    Q1
    FRONTIERS IN PUBLIC HEALTH
    2022.
    DOI:10.3389/fpubh.2022.921226 (Copy DOI)
    18.
    The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future
    Godman, B;Haque, M;Leong, T;Allocati, E;Kumar, S;Islam, S;Charan, J;Akter, F;Kurdi, A;Vassalo, C;Abu Bakar, M;Rahim, SA;Sultana, N;Deeba, F;Khan, MAH;Alam, ABMM;Jahan, I;Kamal, ZM;Hasin, H;Munzur-E-Murshid;Nahar, S;Haque, M;Dutta, S;Abhayanand, JP;Kaur, RJ;Rwegerera, GM;do Nascimento, RCRM;Godói, IPD;Irfan, M;Amu, AA;Matowa, P;Acolatse, J;Incoom, R;Sefah, IA;Acharya, J;Opanga, S;Njeri, LW;Kimonge, D;Kwon, HY;Bae, S;Khuan, KKP;Abubakar, AR;Sani, IH;Khan, TA;Hussain, S;Saleem, Z;Malande, OO;Piloy...
    Q1
    FRONTIERS IN PUBLIC HEALTH
    2021.
    DOI:10.3389/fpubh.2021.671961 (Copy DOI)
    19.
    The Semmelweis Study: a longitudinal occupational cohort study within the framework of the Semmelweis Caring University Model Program for supporting healthy aging
    Ungvari, Z;Tabak, AG;Adany, R;Purebl, G;Kaposvari, C;Fazekas-Pongor, V;Csipo, T;Szarvas, Z;Horvath, K;Mukli, P;Balog, P;Bodizs, R;Ujma, P;Stauder, A;Belsky, DW;Kovacs, I;Yabluchanskiy, A;Maier, AB;Moizs, M;Oestlin, P;Yon, Y;Varga, P;Voko, Z;Papp, M;Takacs, I;Vasarhelyi, B;Torzsa, P;Ferdinandy, P;Csiszar, A;Benyo, Z;Szabo, AJ;Doernyei, G;Kivimaeki, M;Kellermayer, M;Merkely, B
    D1
    GEROSCIENCE
    2024.
    DOI:10.1007/s11357-023-01018-7 (Copy DOI)
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Departmnet of Biophysics and Radiation Biology, Department of Pharmacology and Pharmacotherapy, Department of Laboratory Medicine, Department of Behavioral Sciences, Institute for Preventive Medicine and Public Health, Transzlációs Medicina Intézet, Department of Internal Medicine and Oncology, Department of Family Medicine, Department of Pediatrics, Department of Ophthalmology, Cardiovascular Center, Department of Cardiology – Heart and Vascular Center, Faculty of Sports Medicine, School of PhD Studies, Faculty of Health Sciences, Department of Morphology and Physiology, Department of Clinical Ophthalmology, Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket), Center for Health Technology Assessment, Department of Public Health,
    20.
    Systematic review of real-world studies evaluating the impact of medication non-adherence to endocrine therapies on hard clinical endpoints in patients with non-metastatic breast cancer
    Inotai, A;Agh, T;Maris, R;Erdosi, D;Kovács, S;Kaló, Z;Senkus, E
    D1
    CANCER TREATMENT REVIEWS
    2021.
    DOI:10.1016/j.ctrv.2021.102264 (Copy DOI)
    21.
    Healthcare financing in Egypt: a systematic literature review
    Fasseeh, A;ElEzbawy, B;Adly, W;ElShahawy, R;George, M;Abaza, S;ElShalakani, A;Kaló, Z
    Q1
    JOURNAL OF THE EGYPTIAN PUBLIC HEALTH ASSOCIATION
    2022.
    DOI:10.1186/s42506-021-00089-8 (Copy DOI)
    22.
    Shall We Screen Lung Cancer With Low-Dose Computed Tomography? Cost-Effectiveness in Hungary
    Nagy, B;Szilberhorn, L;Gyorbíró, DM;Moizs, M;Bajzik, G;Kerpel-Fronius, A;Vokó, Z
    Q1
    VALUE IN HEALTH REGIONAL ISSUES
    2023.
    DOI:10.1016/j.vhri.2022.10.002 (Copy DOI)
    23.
    Coverage with evidence development for medical devices in Europe: Can practice meet theory?
    Drummond, M;Federici, C;Reckers-Droog, V;Torbica, A;Blankart, CR;Ciani, O;Kaló, Z;Kovács, S;Brouwer, W
    Q1
    HEALTH ECONOMICS
    2022.
    DOI:10.1002/hec.4478 (Copy DOI)
    24.
    Delayed payment schemes in Central-Eastern Europe and Middle-East
    Adám, I;Callenbach, M;Németh, B;Vreman, RA;Pontén, J;Strbad, T;Dawoud, D;Kostyuk, A;Seyam, A;Nagy, L;Goettsch, WG;Kaló, Z
    Q1
    FRONTIERS IN MEDICINE
    2022.
    DOI:10.3389/fmed.2022.940371 (Copy DOI)
    25.
    Heterogeneous impact of the COVID-19 pandemic on lung, colorectal and breast cancer incidence in Hungary: results from time series and panel data models
    Elek, P;Csanádi, M;Fadgyas-Freyler, P;Gervai, N;Oross-Bécsi, R;Szécsényi-Nagy, B;Tatár, M;Váradi, B;Zemplényi, A
    Q1
    BMJ OPEN
    2022.
    DOI:10.1136/bmjopen-2022-061941 (Copy DOI)
    26.
    Recommendations for patient involvement in health technology assessment in Central and Eastern European countries
    Jakab, I;Dimitrova, M;Houÿez, F;Bereczky, T;Fövényes, M;Maravic, Z;Belina, I;Andriciuc, C;Tóth, K;Piniazhko, O;Hren, R;Gutierrez-Ibarluzea, I;Czech, M;Tesar, T;Niewada, M;Lorenzovici, L;Kamusheva, M;Manova, M;Savova, A;Mitkova, Z;Tachkov, K;Németh, B;Petykó, ZI;Dawoud, D;Delnoij, D;Knies, S;Goettsch, W;Kaló, Z
    Q1
    FRONTIERS IN PUBLIC HEALTH
    2023.
    DOI:10.3389/fpubh.2023.1176200 (Copy DOI)
    27.
    Strategic Approaches to Reducing the Burden of Atopic Dermatitis in the Middle East and Africa Region
    Elezbawy, B;Farghaly, M;Al Lafi, A;Gamal, M;Metni, M;Visser, W;Al-Abdulkarim, H;Hedibel, M;Fasseeh, AN;Abaza, S;Kalo, Z
    Q1
    VALUE IN HEALTH REGIONAL ISSUES
    2024.
    DOI:10.1016/j.vhri.2024.100987 (Copy DOI)
    28.
    Population-level norm values by EQ-5D-3L in Hungary - a comparison of survey results from 2022 with those from 2000
    Inotai, A;Nagy, D;Kaló, Z;Vokó, Z
    Q1
    QUALITY OF LIFE RESEARCH
    2024.
    DOI:10.1007/s11136-024-03699-9 (Copy DOI)
    29.
    Significant improvement in melanoma survival over the last decade: A Hungarian nationwide study between 2011 and 2019
    Liszkay, G;Benedek, A;Polgár, C;Olah, J;Holló, P;Emri, G;Csejtei, A;Kenessey, I;Polányi, Z;Knollmajer, K;Várnai, M;Vokó, Z;Nagy, B;Rokszin, G;Fábián, I;Barcza, Z;Gyulai, R;Kiss, Z
    D1
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
    2023.
    DOI:10.1111/jdv.18960 (Copy DOI)
    30.
    The transferability of health technology assessment: the European perspective with focus on central and Eastern European countries
    Németh, B;Goettsch, W;Kristensen, FB;Piniazhko, O;Huic, M;Tesar, T;Atanasijevic, D;Lipska, I;Kaló, Z
    Q2
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
    2020.
    DOI:10.1080/14737167.2020.1779061 (Copy DOI)
    31.
    Outcome-based reimbursement in Central-Eastern Europe and Middle-East
    Adám, I;Callenbach, M;Németh, B;Vreman, RA;Tollin, C;Pontén, J;Dawoud, D;Elvidge, J;Crabb, N;Van Doorn-Khosrovani, SBV;Pisters-van Roy, A;Vincziczki, A;Almomani, E;Vajagic, M;Oner, ZG;Matni, M;Fürst, J;Kahveci, R;Goettsch, WG;Kaló, Z
    Q1
    FRONTIERS IN MEDICINE
    2022.
    DOI:10.3389/fmed.2022.940886 (Copy DOI)
    32.
    A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt
    Elezbawy, B;Fasseeh, AN;Sedrak, A;Eldessouki, R;Gamal, M;Eldebeiky, M;Amer, H;Akeel, S;Morsy, A;Amin, A;Shafik, A;Abaza, S;Kaló, Z
    Q1
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE
    2022.
    DOI:10.1186/s40545-022-00414-2 (Copy DOI)
    33.
    Framework for Patient Experience Value Elements in Rare Disease: A Case Study Demonstrating the Applicability of Combined Qualitative and Quantitative Methods
    McQueen, RB;Mendola, ND;Jakab, I;Bennett, J;Nair, K;Németh, B;Inotai, A;Kaló, Z
    Q2
    PHARMACOECONOMICS-OPEN
    2023.
    DOI:10.1007/s41669-022-00376-w (Copy DOI)
    34.
    Prioritization of implementation barriers related to integrated care models in Central and Eastern European countries
    Csanádi, M;Kaló, Z;Rutten-van Molken, M;Looman, W;Huic, M;Ercevic, D;Atanasijevic, D;Lorenzovici, L;Petryszyn, P;Pogány, G;Pitter, J;Zemplényi, A
    Q1
    HEALTH POLICY
    2022.
    DOI:10.1016/j.healthpol.2022.08.012 (Copy DOI)
    35.
    Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges
    Daubner-Bendes, R;Kovács, S;Niewada, M;Huic, M;Drummond, M;Ciani, O;Blankart, CR;Mandrik, O;Torbica, A;Yfantopoulos, J;Petrova, G;Holownia-Voloskova, M;Taylor, RS;Al, M;Piniazhko, O;Lorenzovici, L;Tarricone, R;Zemplényi, A;Kaló, Z
    Q1
    FRONTIERS IN PUBLIC HEALTH
    2021.
    DOI:10.3389/fpubh.2020.612410 (Copy DOI)
    36.
    Implementation Road Map of Health Technology Assessment in Middle-Income Countries: The Case of Jordan
    Almomani, E;Alabbadi, I;Fasseeh, A;Al-Qutob, R;Al-Sharu, E;Hayek, N;Tarawneh, MR;Kaló, Z
    Q2
    VALUE IN HEALTH REGIONAL ISSUES
    2021.
    DOI:10.1016/j.vhri.2021.01.003 (Copy DOI)
    37.
    Humanistic and Economic Burden of Atopic Dermatitis for Adults and Adolescents in the Middle East and Africa Region
    Elezbawy, B;Fasseeh, AN;Fouly, E;Tannira, M;Dalle, H;Aderian, S;Abu Esba, LC;Al Abdulkarim, H;Ammoury, A;Altawil, E;Al Turaiki, A;Albreiki, F;Al-Haddab, M;Al-Lafi, A;Alowayesh, M;Al-Sheikh, A;Elsayed, M;Elshamy, A;Eshmawi, M;Farag, A;Hamadah, I;Hedibel, M;Kannenberg, S;Karam, R;Metni, M;Raboobee, N;Steinhoff, M;Abaza, S;Farghaly, M;Kaló, Z
    D1
    DERMATOLOGY AND THERAPY
    2023.
    DOI:10.1007/s13555-022-00857-0 (Copy DOI)
    38.
    The Role of Patient Experience in the Value Assessment of Complex Technologies - Do HTA Bodies Need to Reconsider How Value is Assessed?
    Sarri, G;Freitag, A;Szegvari, B;Mountian, I;Brixner, D;Bertelsen, N;Kaló, Z;Upadhyaya, S
    Q1
    HEALTH POLICY
    2021.
    DOI:10.1016/j.healthpol.2021.03.006 (Copy DOI)
    39.
    Biosimilars are essential for sustainable healthcare systems; however, key challenges remain as seen with long-acting insulin analogues
    Godman, B.; Tubic, B.; Allocati, E.; Wladysiuk, M.; McTaggart, S.; Kurdi, A.; Haque, M.; MacBride-Stewart, S.; Kalemeera, F.; Massele, A.; Hoxha, I.; Pekovic, V.M.; Petrova, G.; Tachkov, K.; Laius, O.; Harsanyi, A.; Inotai, A.; Jakupi, A.; Henkuzens, S.; Garuolienė, K.; Bonanno, P.V.; Rutkowski, J.; Mardare, I.; Fürst, J.; Pontes, C.; Zara, C.; Pedrola, M.T.; Akter, F.; Kwon, H.-Y.; Martin, A.P.; Banzi, R.; Wale, J.; Gulbinovič, J.;
    Q2
    JOURNAL OF APPLIED PHARMACEUTICAL SCIENCE 2231-3354
    2022.
    DOI:10.7324/JAPS.2022.120306 (Copy DOI)
    40.
    Changing Trends in Melanoma Incidence and Decreasing Melanoma Mortality in Hungary Between 2011 and 2019: A Nationwide Epidemiological Study
    Liszkay, G;Kiss, Z;Gyulai, R;Olah, J;Holló, P;Emri, G;Csejtei, A;Kenessey, I;Benedek, A;Polányi, Z;Nagy-Erdei, Z;Daniel, A;Knollmajer, K;Várnai, M;Vokó, Z;Nagy, B;Rokszin, G;Fábián, I;Barcza, Z;Polgár, C
    Q1
    FRONTIERS IN ONCOLOGY
    2021.
    DOI:10.3389/fonc.2020.612459 (Copy DOI)
    41.
    Decreasing incidence and mortality of lung cancer in Hungary between 2011 and 2021 revealed by robust estimates reconciling multiple data sources
    Gálffy, G;Szabó, GT;Tamási, L;Müller, V;Moldvay, J;Sárosi, V;Kerpel-Fronius, A;Kardos, T;Csada, E;Pápai-Székely, Z;Szász, Z;Király, Z;Hódi, G;Kovács, Z;Balogh, E;Kovács, KA;Darida, M;Buga, V;Rokszin, G;Abonyi-Tóth, Z;Kiss, Z;Vokó, Z;Bogos, K
    Q2
    PATHOLOGY & ONCOLOGY RESEARCH
    2024.
    DOI:10.3389/pore.2024.1611754 (Copy DOI)
    42.
    Assessing the Consequences of External Reference Pricing for Global Access to Medicines and Innovation: Economic Analysis and Policy Implications
    Incze, A;Kalo, Z;Espin, J;Kiss, E;Kessabi, S;Garrison, LP
    Q1
    FRONTIERS IN PHARMACOLOGY
    2022.
    DOI:10.3389/fphar.2022.815029 (Copy DOI)
    43.
    Burden of Chronic Heart Failure in Romania
    Lorenzovici, L;Barzan-Székely, A;Farkas-Ráduly, S;Pana, BC;Csanádi, M;Chiriac, ND;Kaló, Z
    Q2
    HEALTHCARE
    2022.
    DOI:10.3390/healthcare10010107 (Copy DOI)
    44.
    Modeling costs and benefits of the organized colorectal cancer screening programme and its potential future improvements in Hungary
    Csanádi, M;Gini, A;Koning, HD;Széles, G;Pitter, JG;Oroszi, B;Pataki, P;Fadgyas-Freyler, P;Korponai, G;Vokó, Z;Lansdorp-Vogelaar, I
    Q2
    JOURNAL OF MEDICAL SCREENING
    2021.
    DOI:10.1177/0969141320968598 (Copy DOI)
    45.
    A concept for multi-winner tenders for medicinal products with balancing between efficient prices, long-term competition and sustainability of supply
    Németh, G;Mágó, ML;Kaló, Z;Lám, J;Balogh, T;Brodszky, V
    Q1
    FRONTIERS IN MEDICINE
    2023.
    DOI:10.3389/fmed.2023.1282698 (Copy DOI)
    46.
    Significant changes in advanced lung cancer survival during the past decade in Hungary: impact of modern immunotherapy and the COVID-19 pandemic
    Kiss, Z;Gálffy, G;Müller, V;Moldvay, J;Sárosi, V;Pápai-Székely, Z;Csada, E;Kerpel-Fronius, A;Király, Z;Szász, Z;Hódi, G;Polányi, Z;Kovács, K;Karamousouli, E;Knollmajer, K;Szabo, TG;Berta, A;Vokó, Z;Rokszin, G;Abonyi-Tóth, Z;Barcza, Z;Tamási, L;Bogos, K
    Q2
    FRONTIERS IN ONCOLOGY
    2023.
    DOI:10.3389/fonc.2023.1207295 (Copy DOI)
    47.
    Systematic literature review of health economic models developed for multiple myeloma to support future analyses
    Choon-Quinones, M;Zelei, T;Németh, B;Tóth, M;Jia, XY;Barnett, M;Keown, P;Durie, B;Harousseau, JL;Hose, D;Kaló, Z
    Q1
    JOURNAL OF MEDICAL ECONOMICS
    2023.
    DOI:10.1080/13696998.2022.2144056 (Copy DOI)
    48.
    Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making
    Németh, B;Kamusheva, M;Mitkova, Z;Petykó, ZI;Zemplényi, A;Dimitrova, M;Tachkov, K;Balkányi, L;Czech, M;Dawoud, D;Goettsch, W;Hren, R;Knies, S;Lorenzovici, L;Maravic, Z;Piniazhko, O;Zerovnik, S;Kaló, Z
    Q2
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH
    2023.
    DOI:10.57264/cer-2022-0157 (Copy DOI)
    49.
    Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016
    Tamasi, L;Horváth, K;Kiss, Z;Bogos, K;Ostoros, G;Müller, V;Urbán, L;Bittner, N;Sárosi, V;Vastag, A;Polányi, Z;Nagy-Erdei, Z;Daniel, A;Nagy, B;Rokszin, G;Abonyi-Tóth, Z;Moldvay, J;Vokó, Z;Gálffy, G
    Q2
    PATHOLOGY & ONCOLOGY RESEARCH
    2021.
    DOI:10.3389/pore.2021.598862 (Copy DOI)
    50.
    International practices in health technology assessment and public financing of digital health technologies: recommendations for Hungary
    Mezei, F;Horváth, K;Pálfi, M;Lovas, K;Adám, I;Túri, G
    Q1
    FRONTIERS IN PUBLIC HEALTH
    2023.
    DOI:10.3389/fpubh.2023.1197949 (Copy DOI)
    51.
    Patient and Caregiver Experience Decision Factors in Treatment Decision Making: Results of a Systematic Literature Review of Multiple Myeloma Decision Aids
    Choon-Quinones, M;Hose, D;Kaló, Z;Zelei, T;Harousseau, JL;Durie, B;Keown, P;Barnett, M;Jakab, I
    D1
    VALUE IN HEALTH
    2022.
    DOI:10.1016/j.jval.2022.04.003 (Copy DOI)
    52.
    A Systematic Literature Review of Gaps and Challenges in Value Assessment of Biosimilars: An ISPOR Special Interest Group Report
    Moorkens, E;Lacosta, TB;Dawoud, D;Inotai, A;Janodia, M;Tan, CJ;Lim, KK;Khatri, N;Pereira, CL;Simoens, S
    D1
    VALUE IN HEALTH
    2023.
    DOI:10.1016/j.jval.2023.04.007 (Copy DOI)
    53.
    Implementation of coverage with evidence development schemes for medical devices: A decision tool for late technology adopter countries
    Kovács, S;Kaló, Z;Daubner-Bendes, R;Kolasa, K;Hren, R;Tesar, T;Reckers-Droog, V;Brouwer, W;Federici, C;Drummond, M;Zemplényi, AT
    Q1
    HEALTH ECONOMICS
    2022.
    DOI:10.1002/hec.4504 (Copy DOI)
    54.
    Regulatory and HTA early dialogues in medical devices
    Blankart, CR;Dams, F;Penton, H;Kaló, Z;Zemplényi, A;Shatrov, K;Iskandar, R;Federici, C
    Q1
    HEALTH POLICY
    2021.
    DOI:10.1016/j.healthpol.2021.07.010 (Copy DOI)
    55.
    Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries
    Dimitrova, M;Jakab, I;Mitkova, Z;Kamusheva, M;Tachkov, K;Nemeth, B;Zemplenyi, A;Dawoud, D;Delnoij, DMJ;Houÿez, F;Kalo, Z
    Q1
    FRONTIERS IN PUBLIC HEALTH
    2022.
    DOI:10.3389/fpubh.2022.922708 (Copy DOI)
    56.
    Impact of health technology assessment implementation with a special focus on middle-income countries
    Fasseeh, AN;Saragih, SM;Hayek, N;Brodovska, S;Ismail, A;ElShalakani, A;Abaza, S;Obeng, GD;Ameyaw, D;Kalo, Z
    Q1
    HEALTH POLICY AND TECHNOLOGY
    2022.
    DOI:10.1016/j.hlpt.2022.100688 (Copy DOI)
    57.
    Recommendation for a Pilot MCDA Tool to Support the Value-Based Purchasing of Generic Medicines in the UAE
    Farghaly, MN;Al Dallal, SAM;Fasseeh, AN;Monsef, NA;Suliman, EAMA;Tahoun, MA;Abaza, S;Kaló, Z
    Q1
    FRONTIERS IN PHARMACOLOGY
    2021.
    DOI:10.3389/fphar.2021.680737 (Copy DOI)
    58.
    Should Hungary Pay More for a QALY Gain than Higher-Income Western European Countries?
    Kovács, S;Németh, B;Erdosi, D;Brodszky, V;Boncz, I;Kaló, Z;Zemplényi, A
    Q1
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY
    2022.
    DOI:10.1007/s40258-021-00710-z (Copy DOI)
    59.
    Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals
    Szekanecz, Z;Vokó, Z;Surján, O;Rákóczi, E;Szamosi, S;Szucs, G;Szekanecz, É;Müller, C;Kiss, Z
    Q1
    FRONTIERS IN IMMUNOLOGY
    2023.
    DOI:10.3389/fimmu.2023.1247129 (Copy DOI)
    60.
    Beyond medicines' barriers: exploring the true cost of multiple myeloma
    Choon-Quinones, M;Zelei, T;Barnett, M;Keown, P;Durie, B;Kalo, Z;Almasi, T;Harousseau, JL;Hose, D
    Q2
    JOURNAL OF MEDICAL ECONOMICS
    2022.
    DOI:10.1080/13696998.2022.2133823 (Copy DOI)
    61.
    Current and future perspectives for the implementation of health technology assessment in Romania
    Rais, C;Kaló, Z;Csanádi, M;Negulescu, V
    Q3
    HEALTH POLICY AND TECHNOLOGY
    2020.
    DOI:10.1016/j.hlpt.2019.11.007 (Copy DOI)
    62.
    Patient and Payer Preferences for Additional Value Criteria
    Jakab, I;Whittington, MD;Franklin, E;Raiola, S;Campbell, JD;Kaló, Z;McQueen, RB
    Q1
    FRONTIERS IN PHARMACOLOGY
    2021.
    DOI:10.3389/fphar.2021.690021 (Copy DOI)
    63.
    Implementation of palliative care consult Service in Hungary - integration barriers and facilitators
    Zemplényi, AT;Csikós, A;Csanádi, M;Rutten-van Mölken, M;Hernandez, C;Pitter, JG;Czypionka, T;Kraus, M;Kaló, Z
    Q1
    BMC PALLIATIVE CARE
    2020.
    DOI:10.1186/s12904-020-00541-0 (Copy DOI)
    64.
    Cost-effectiveness of genetic-based screening strategies for maturity-onset diabetes of the young
    Kovacs, G;Nagy, D;Szilberhorn, L;Zelei, T;Gaal, Z;Vellekoop, H;Huygens, S;Versteegh, M;Mölken, MRV;Koleva-Kolarova, R;Tsiachristas, A;Wordsworth, S;Nagy, B
    Q3
    PERSONALIZED MEDICINE
    2023.
    DOI:10.2217/pme-2023-0023 (Copy DOI)
    65.
    Identifying Patient Access Barriers for Tumor Necrosis Factor Alpha Inhibitor Treatments in Rheumatoid Arthritis in Five Central Eastern European Countries
    Inotai, A;Tomek, D;Niewada, M;Lorenzovici, L;Kolek, M;Weber, J;Kurrat, AK;Kiss, EV;Kaló, Z
    Q1
    FRONTIERS IN PHARMACOLOGY
    2020.
    DOI:10.3389/fphar.2020.00845 (Copy DOI)
    66.
    Focus group study on perceptions and information needs regarding vaccines targeting the older population: a cross-country comparison in four European countries
    Wennekes, MD;Eilers, R;Caputo, A;Gagneux-Brunon, A;Gavioli, R;Nicoli, F;Vokó, Z;Timen, A
    D1
    GEROSCIENCE
    2023.
    DOI:10.1007/s11357-022-00682-5 (Copy DOI)
    67.
    Potential Cost-Savings From the Use of the Biosimilars in Slovakia
    Tesar, T;Golias, P;Kobliskova, Z;Wawruch, M;Kawalec, P;Inotai, A
    Q2
    FRONTIERS IN PUBLIC HEALTH
    2020.
    DOI:10.3389/fpubh.2020.00431 (Copy DOI)
    68.
    Development of a core evaluation framework of value-added medicines: report 1 on methodology and findings
    Petykó, ZI;Kaló, Z;Espin, J;Podrazilová, K;Tesar, T;Maniadakis, N;Fricke, FU;Inotai, A
    Q2
    COST EFFECTIVENESS AND RESOURCE ALLOCATION
    2021.
    DOI:10.1186/s12962-021-00311-6 (Copy DOI)
    69.
    Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011-2020
    Kiss, Z;Kocsis, J;Nikolényi, A;Horváth, Z;Knollmajer, K;Benedek, A;Várnai, M;Polányi, Z;Kovács, KA;Berta, A;Köveskuti, I;Karamousouli, E;Szabó, TG;Rokszin, G;Fábián, I;Tamás, RB;Surján, O;Fürtos, D;Surján, G;Kenessey, I;Weber, A;Barcza, Z;Berki, T;Vokó, Z;Dózsa, C;Dank, M;Boér, K
    Q2
    FRONTIERS IN ONCOLOGY
    2023.
    DOI:10.3389/fonc.2023.1182170 (Copy DOI)
    70.
    Barriers and facilitators of exploiting the potential of value-added medicines
    Petykó, ZI;Inotai, A;Holtorf, AP;Brixner, D;Kaló, Z
    Q2
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
    2020.
    DOI:10.1080/14737167.2020.1758558 (Copy DOI)
    71.
    Using real-world evidence in healthcare from Western to Central and Eastern Europe: a review of existing barriers
    Kamusheva, M;Németh, B;Zemplényi, A;Kaló, Z;Elvidge, J;Dimitrova, M;Pontén, J;Tachkov, K;Mitkova, Z
    Q2
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH
    2022.
    DOI:10.2217/cer-2022-0065 (Copy DOI)
    72.
    Potential Criteria for Frameworks to Support the Evaluation of Innovative Medicines in Upper Middle-Income Countries-A Systematic Literature Review on Value Frameworks and Multi-Criteria Decision Analyses
    Jakab, I;Németh, B;Elezbawy, B;Karadayi, MA;Tozan, H;Aydin, S;Shen, J;Kaló, Z
    Q1
    FRONTIERS IN PHARMACOLOGY
    2020.
    DOI:10.3389/fphar.2020.01203 (Copy DOI)
    73.
    The budget impact of lung cancer screening with low-dose computed tomography
    Nagy, B;Szilbehorn, L;Kerpel-Fronius, A;Moizs, M;Bajzik, G;Vokó, Z
    Q4
    ORVOSI HETILAP
    2021.
    DOI:10.1556/650.2021.32095 (Copy DOI)
    74.
    Significant Regional Differences in Lung Cancer Incidence in Hungary: Epidemiological Study Between 2011 and 2016
    Galffy, G;Vastag, A;Bogos, K;Zoltan, K;Ostoros, G;Müller, V;Urbán, L;Bittner, N;Sárosi, V;Polányi, Z;Nagy-Erdei, Z;Daniel, A;Knollmajer, K;Várnai, M;Szegner, P;Vokó, Z;Nagy, B;Horváth, K;Rokszin, G;Abonyi-Tóth, Z;Pozsgai, E;Barcza, Z;Moldvay, J;Tamási, L
    Q2
    PATHOLOGY & ONCOLOGY RESEARCH
    2021.
    DOI:10.3389/pore.2021.1609916 (Copy DOI)
    75.
    Capacity Building for Health Technology Assessment in Jordan: Institutionalization and Its Use in Pricing and Reimbursement Decisions
    Almomani, E;Hammad, EA;AlQutob, R;Abu Hammour, K;Al-Sharu, E;Abu-Shaer, M;Alabbadi, I;Kaló, Z
    Q2
    VALUE IN HEALTH REGIONAL ISSUES
    2022.
    DOI:10.1016/j.vhri.2022.07.006 (Copy DOI)
    76.
    Health technology assessment in T?rkiye: Current status and perspectives on future implementation
    Atikeler, EK;Fasseeh, AN;Mantel-Teeuwisse, AK;Çaliskan, Z;Öner, ZG;Kizilay, H;Kalo, Z;Goettsch, W
    Q1
    HEALTH POLICY AND TECHNOLOGY
    2023.
    DOI:10.1016/j.hlpt.2022.100701 (Copy DOI)
    77.
    The Impact of Reimbursement Practices on the Pharmaceutical Market for Off-Patent Medicines in Slovakia
    Tesar, T;Golias, P;Masarykova, L;Kawalec, P;Inotai, A
    Q1
    FRONTIERS IN PHARMACOLOGY
    2021.
    DOI:10.3389/fphar.2021.795002 (Copy DOI)
    78.
    A roadmap toward implementing health technology assessment in Egypt
    Fasseeh, AN;Elezbawy, B;Gamal, M;Seyam, A;Abourawash, A;George, M;Anwar, M;Amin, M;Khalifa, AY;Elshalakani, A;Hatem, A;Abdelhamid, S;Elsamouly, H;Fasseeh, N;Adel, R;Dawood, H;Abaza, S;Kaló, Z
    Q1
    FRONTIERS IN PUBLIC HEALTH
    2022.
    DOI:10.3389/fpubh.2022.896175 (Copy DOI)
    79.
    Maximizing the benefits of using biosimilars in Egypt
    Fasseeh, AN;Elezbawy, B;El-Fass, KA;GamaI, M;Seyam, A;Hayek, N;Rahman, NA;Abdelhamid, S;Fasseeh, N;Saad, AS;Elagamy, A;Mahmoud, A;Sedrak, AS;Elshazly, K;Eldebeiky, M;Talaat, M;Mohamed, NM;Abdelaziz, RA;Refaat, R;Akeel, S;Abaza, S;Kalo, Z
    Q1
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE
    2023.
    DOI:10.1186/s40545-023-00581-w (Copy DOI)
    80.
    Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications
    Godman, B;Wladysiuk, M;McTaggart, S;Kurdi, A;Allocati, E;Jakovljevic, M;Kalemeera, F;Hoxha, I;Nachtnebel, A;Sauermann, R;Hinteregger, M;Markovic-Pekovic, V;Tubic, B;Petrova, G;Tachkov, K;Slaby, J;Nejezchlebova, R;Krulichová, IS;Laius, O;Selke, G;Langner, I;Harsanyi, A;Inotai, A;Jakupi, A;Henkuzens, S;Garuoliene, K;Gulbinovic, J;Bonanno, PV;Rutkowski, J;Ingeberg, S;Melien, O;Mardare, I;Fürst, J;MacBride-Stewart, S;Holmes, C;Pontes, C;Zara, C;Pedrola, MT;Hoffmann, M;Kourafalos, V;Pisana, A;Banzi...
    Q2
    BIOMED RESEARCH INTERNATIONAL
    2021.
    DOI:10.1155/2021/9996193 (Copy DOI)
    81.
    Cost-effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries
    Szilberhorn, L;Zelei, T;Vellekoop, H;Huygens, S;Versteegh, M;Rutten-van Mölken, MRV;Koleva-Kolarova, R;Tsiachristas, A;Wordsworth, S;Nagy, B
    Q3
    PERSONALIZED MEDICINE
    2023.
    DOI:10.2217/pme-2023-0017 (Copy DOI)
    82.
    Time trade-off health state utility values for depression: a systematic review and meta-analysis
    Balázs, PG;Erdosi, D;Zemplényi, A;Brodszky, V
    Q1
    QUALITY OF LIFE RESEARCH
    2023.
    DOI:10.1007/s11136-022-03253-5 (Copy DOI)
    83.
    Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives
    Kaló, Z;Petykó, ZI;Fricke, FU;Maniadakis, N;Tesar, T;Podrazilová, K;Espin, J;Inotai, A
    Q2
    COST EFFECTIVENESS AND RESOURCE ALLOCATION
    2021.
    DOI:10.1186/s12962-021-00296-2 (Copy DOI)
    84.
    Retrospective cost-utility analysis of the Non-typhoidal Salmonella control programme in Hungary
    Országh, E;Pitter, JG;Kaló, Z;Vokó, Z;Józwiak, A
    D1
    FOOD CONTROL
    2021.
    DOI:10.1016/j.foodcont.2020.107529 (Copy DOI)
    85.
    Association between transplant glomerulopathy and graft outcomes following kidney transplantation: A meta-analysis
    Kovács, G;Devercelli, G;Zelei, T;Hirji, I;Vokó, Z;Keown, PA
    D1
    PLOS ONE
    2020.
    DOI:10.1371/journal.pone.0231646 (Copy DOI)
    86.
    A multicriteria decision analysis (MCDA) tool to purchase implantable medical devices in Egypt
    Elezbawy, B;Fasseeh, AN;Németh, B;Gamal, M;Eldebeiky, M;Refaat, R;Taha, A;Rabiea, S;Abdallah, M;Ramadan, S;Noaman, H;Eldin, AB;Mostafa, H;Nouh, S;Zaki, A;Abdelrahman, M;Abaza, S;Kalò, Z
    Q1
    BMC MEDICAL INFORMATICS AND DECISION MAKING
    2022.
    DOI:10.1186/s12911-022-02025-y (Copy DOI)
    87.
    Underlying reasons for post-mortem diagnosed lung cancer cases - A robust retrospective comparative study from Hungary (HULC study)
    Kiss, ZN;Bogos, K;Tamási, L;Ostoros, G;Müller, V;Bittner, N;Sárosi, V;Vastag, A;Knollmajer, K;Várnai, M;Kovács, K;Berta, A;Köveskuti, I;Karamousouli, E;Rokszin, G;Abonyi-Tóth, Z;Barcza, Z;Kenessey, I;Weber, A;Nagy, P;Freyler-Fadgyas, P;Szócska, M;Szegner, P;Hilbert, L;Géczy, GB;Surján, G;Moldvay, J;Vokó, Z;Gálffy, G;Polányi, Z
    Q2
    FRONTIERS IN ONCOLOGY
    2022.
    DOI:10.3389/fonc.2022.1032366 (Copy DOI)
    88.
    The humanistic and economic burden of atopic dermatitis among adults and adolescents in Saudi Arabia
    Elezbawy, B;Fasseeh, AN;Fouly, E;Abu Esba, LC;Al Abdulkarim, H;Al-Haddab, M;Al-Sheikh, A;Altawil, E;Al Turaiki, A;Eshmawi, M;Hamadah, I;Tannira, M;Dalle, H;Aderian, S;Roshdy, A;Jaheen, A;Hamad, T;Abaza, S;Kaló, Z
    Q2
    JOURNAL OF MEDICAL ECONOMICS
    2022.
    DOI:10.1080/13696998.2022.2152234 (Copy DOI)
    89.
    Proposal for capturing patient experience through extended value frameworks o f health technologies
    Inotai, A;Jakab, I;Brixner, D;Campbell, JD;Hawkins, N;Kristensen, LE;Charokopou, M;Mountian, I;Szegvari, B;Kaló, Z
    D1
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY
    2021.
    DOI:10.18553/jmcp.2021.27.7.936 (Copy DOI)
    90.
    ACUTE SARS-CoV-2 INFECTION AND SEROPOSITIVITY AMONG HEALTHCARE WORKERS AND MEDICAL STUDENTS IN SUMMER 2020, HUNGARY
    Kosztin, A;Merkely, B;Szabó, AJ;Blaha, B;Varga, P;Vásárhelyi, B;Vokó, Z
    Q2
    INTERNATIONAL JOURNAL OF OCCUPATIONAL MEDICINE AND ENVIRONMENTAL HEALTH
    2022.
    DOI:10.13075/ijomeh.1896.01804 (Copy DOI)
    91.
    Systematic literature review of the epidemiology of glycogen storage disease type 1a
    Zelei, T.; Kovács, S.; Finn, P.; Nagy, D.; Sikirica, V.; Carlson, K.B.; Vokó, Z.;
    Q2
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY AND METABOLISM 0334-018X 2191-0251
    2023.
    DOI:10.1515/jpem-2023-0127 (Copy DOI)
    92.
    Goals and methods of managed entry agreements-can we get what we want?
    Ispán, F;Hegedüs, T;Csanádi, M;Nagy, B
    Q1
    HEALTH POLICY AND TECHNOLOGY
    2023.
    DOI:10.1016/j.hlpt.2023.100745 (Copy DOI)
    93.
    Cost-Effectiveness of Bariatric Surgery in Patients Living with Obesity and Type 2 Diabetes
    Kovács, G;Mohos, E;Kis, JT;Tabák, A;Gerendy, P;Pettkó, J;Nagy, D;Gyorbíró, D;Kaló, Z
    Q2
    JOURNAL OF DIABETES RESEARCH
    2023.
    DOI:10.1155/2023/9686729 (Copy DOI)
    94.
    National level adjustments to the challenges of the SARS-CoV2 pandemic on blood banking operations
    Matusovits, A;Nagy, S;Baróti-Tóth, K;Nacsa, J;Lázár, M;Marton, I;Andrikovics, H;Vokó, Z;Tordai, A
    Q2
    TRANSFUSION
    2021.
    DOI:10.1111/trf.16346 (Copy DOI)
    95.
    Development of transferability guidance for integrated care models with special focus on Central and Eastern European countries
    Kaló, Z;Zemplényi, A;Rutten-van Mölken, M;Looman, W;Huic, M;Hacek, RT;Petrova, G;Piniazhko, O;Tesar, T;Csanádi, M;Pitter, JG
    Q3
    CROATIAN MEDICAL JOURNAL
    2020.
    DOI:10.3325/cmj.2020.61.252 (Copy DOI)
    96.
    Secondary primary malignancies after treatment with chemo-immunotherapy in treatment-naive patients with CLL: a systematic literature review
    Csanádi, M;Agh, T;Tordai, A;Tapprich, C;Vokó, Z;Stamatopoulos, K
    Q2
    EXPERT REVIEW OF HEMATOLOGY
    2022.
    DOI:10.1080/17474086.2022.2042246 (Copy DOI)
    97.
    Early palliative care associated with lower costs for adults with advanced cancer: evidence from Hungary
    Zemplényi, AT;Csikós, A;Fadgyas-Freyler, P;Csanádi, M;Kaló, Z;Pozsgai, É;Rutten-van Mölken, M;Pitter, JG
    Q3
    EUROPEAN JOURNAL OF CANCER CARE
    2021.
    DOI:10.1111/ecc.13473 (Copy DOI)
    98.
    New opportunities offered by digital technology in melanoma malignum screening
    Farkas-Ráduly, F;Csanádi, M;Agh, T;Szász, O;Vokó, Z;Széles, G
    Q4
    ORVOSI HETILAP
    2022.
    DOI:10.1556/650.2022.32613 (Copy DOI)
    99.
    The role of low-dose computed tomography in lung cancer screening
    Agh, TM;Szilberhorn, LL;Csanadi, MRC;Széles, YR;Vokó, OT;Adám, GBR;Kallai, ARP
    Q4
    ORVOSI HETILAP
    2022.
    DOI:10.1556/650.2022.32583 (Copy DOI)
    100.
    Review of the scientific literature on the use of automated breast ultrasound for screening
    Tittmann, J;Csanádi, M;Agh, T;Széles, G;Vokó, Z;Ormándi, K;Kallai, A
    Q4
    ORVOSI HETILAP
    2022.
    DOI:10.1556/650.2022.32565 (Copy DOI)
    101.
    Restenosis rates in patients with ipsilateral carotid endarterectomy and contralateral carotid artery stenting
    Nguyen, DT;Vokó, B;Nyárádi, BB;Munkácsi, T;Bérczi, A;Vokó, Z;Dósa, E
    Q1
    PLOS ONE
    2022.
    DOI:10.1371/journal.pone.0262735 (Copy DOI)
    102.
    A tüdőrák hazai epidemiológiai adatai új megközelítésben
    Bogos, Krisztina; Kiss, Zoltán; Gálffy, Gabriella; Tamási, Lilla; Ostoros, Gyula; Müller, Veronika; Urbán, László; Bittner, Nóra; Sárosi, Veronika; Vastag, Aladár; Polányi, Zoltán; Nagy-Erdei, Zsófia; Vokó, Zoltán; Nagy, Balázs; Rokszin, György; Abonyi-Tóth, Zsolt; Moldvay, Judit;
    Q4
    MAGYAR ONKOLÓGIA 0025-0244 2060-0399
    2020.
    103.
    Supporting role of non-governmental health insurance schemes in the implementation of universal health coverage in developing countries
    Almási, Tímea; Abul-Magd, Ehab; George, Mohsen; Arnaiz, Fernando; Elezbawy, Baher; Nagy, Balázs; Kaló, Zoltán;
    JOURNAL OF HEALTH POLICY AND OUTCOMES RESEARCH 2299-1247 2543-604X
    2020.
    DOI:10.7365/JHPOR.2020.1.4 (Copy DOI)
    104.
    Improving Quality Indicator of Melanoma Management - Change of Melanoma Mortality-to-Incidence Rate Ratio Based on a Hungarian Nationwide Retrospective Study
    Varnai, M;Kiss, Z;Gyulai, R;Olah, J;Hollo, P;Emri, G;Csejtei, A;Kenessey, I;Benedek, A;Polanyi, Z;Nagy-Erdei, Z;Daniel, A;Knollmajer, K;Rokszin, G;Fabian, I;Barcza, Z;Polgar, C;Nagy, B;Liszkay, G;Voko, Z
    Q1
    FRONTIERS IN ONCOLOGY
    2021.
    DOI:10.3389/fonc.2021.745550 (Copy DOI)
    105.
    Implementation of evidence-based health policy in the field of integrated care The planning process of the Hungarian National Resource Centre for Rare Diseases
    Gábor, P;Marcell, C;György, PJ;Tamás, ZA;Éva, B;Zsuzsanna, B;Judit, K;Petra, FF;Lajos, S;Zoltán, K
    Q4
    ORVOSI HETILAP
    2021.
    DOI:10.1556/650.2021.32244 (Copy DOI)
    106.
    Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia
    Lorenzovici, L;Szilberhorn, L;Farkas-Ráduly, S;Gasparik, AI;Precup, AM;Nagy, AG;Niemann, CU;Aittokallio, T;Kaló, Z;Csanádi, M
    D1
    BIODRUGS
    2023.
    DOI:10.1007/s40259-023-00583-9 (Copy DOI)
    107.
    Increase in the Length of Lung Cancer Patient Pathway Before First-Line Therapy: A 6-Year Nationwide Analysis From Hungary
    Kiss, Z;Bogos, K;Tamasi, L;Ostoros, G;Mueller, V;Urban, L;Bittner, N;Sarosi, V;Vastag, A;Polanyi, Z;Nagy-Erdei, Z;Knollmajer, K;Varnai, M;Nagy, B;Horvath, K;Rokszin, G;Abonyi-Toth, Z;Barcza, Z;Moldvay, J;Galffy, G;Voko, Z
    Q2
    PATHOLOGY & ONCOLOGY RESEARCH
    2021.
    DOI:10.3389/pore.2021.1610041 (Copy DOI)
    108.
    Improved survival of non-small cell lung cancer patients after introducing patient navigation: A retrospective cohort study with propensity score weighted historic control
    Pitter, JG;Moizs, M;Ezer, ÉS;Lukács, G;Szigeti, A;Repa, I;Csanádi, M;Rutten-van Mölken, MPMH;Islam, K;Kaló, Z;Vokó, Z
    Q1
    PLOS ONE
    2022.
    DOI:10.1371/journal.pone.0276719 (Copy DOI)
    109.
    Development of a breast cancer screening protocol to use automated breast ultrasound in a local setting
    Tittmann, J;Csanádi, M;Agh, T;Széles, G;Vokó, Z;Kallai, A
    Q1
    FRONTIERS IN PUBLIC HEALTH
    2023.
    DOI:10.3389/fpubh.2022.1071317 (Copy DOI)
    110.
    Survival of propionic acidemia patients with liver transplant
    Zelei, T;Vokó, Z;Németh, B;Petykó, Z;Banerjee, G;Sikirica, V
    Q3
    MOLECULAR GENETICS AND METABOLISM REPORTS
    2024.
    DOI:10.1016/j.ymgmr.2024.101093 (Copy DOI)
    111.
    Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography: Comparing Hungarian Screening Protocols with the US NLST
    Rajabi, T;Szilberhorn, L;Gyorbiro, D;Tatár, M;Vokó, Z;Nagy, B
    Q1
    CANCERS
    2024.
    DOI:10.3390/cancers16172933 (Copy DOI)
    112.
    Breast cancer stage and molecular subtype distribution: real-world insights from a regional oncological center in Hungary
    Tittmann, J;Agh, T;Erdsiö, D;Csanády, B;Kövér, E;Zemplényi, A;Kovács, S;Vokó, Z
    Q2
    DISCOVER ONCOLOGY
    2024.
    DOI:10.1007/s12672-024-01096-9 (Copy DOI)
    113.
    Associations between classroom networks and health behaviour of adolescents
    Varsányi, P;Tóth, G;Vitrai, J;Vokó, Z
    Q3
    JOURNAL OF PUBLIC HEALTH-HEIDELBERG
    2023.
    DOI:10.1007/s10389-021-01690-z (Copy DOI)
    114.
    The applicability of health technology assessment and risk-benefit analysis in the field of food safety
    Országh, E;Józwiak, A;Süth, M;Micsinai, A;Urbányi, B;Vokó, Z;Kaló, Z;Pitter, JG
    Q4
    MAGYAR ALLATORVOSOK LAPJA
    2021.
    115.
    Facilitators and Barriers of Incremental Innovation by Fixed Dose Combinations in Cardiovascular Diseases
    Inotai, A;Kaló, Z;Petykó, Z;Gyöngyoesi, K;O'Keeffe, DT;Czech, M;Agh, T
    Q1
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE
    2024.
    DOI:10.3390/jcdd11070186 (Copy DOI)
    116.
    Mapping Health Technology Assessment Agency Approaches for Biosimilar Value Assessment: An ISPOR Special Interest Group Report
    Lacosta, TB;Inotai, A;Pereira, CL;Barbier, L;Simoens, S
    D1
    VALUE IN HEALTH
    2024.
    DOI:10.1016/j.jval.2024.01.018 (Copy DOI)
    117.
    The hidden burden of atopic dermatitis in central and Eastern European countries
    Elezbawy, B;Kaló, Z;Fasseeh, A;Inotai, A;Nemeth, B;Agh, T
    Q2
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
    2024.
    DOI:10.1080/14737167.2024.2416249 (Copy DOI)
    118.
    Using informative prior based on expert opinion in Bayesian estimation of the transition probability matrix in Markov modelling-an example from the cost-effectiveness analysis of the treatment of patients with predominantly negative symptoms of schizophre
    Vokó, Z;Bitter, I;Mersich, B;Réthelyi, J;Molnár, A;Pitter, JG;Götze, A;Horváth, M;Kóczián, K;Fonticoli, L;Lelli, F;Németh, B
    Q2
    COST EFFECTIVENESS AND RESOURCE ALLOCATION
    2020.
    DOI:10.1186/s12962-020-00224-w (Copy DOI)
    119.
    Incremental cost of premature birth - a public health care payer perspective from Hungary
    Kovács, G;Abonyi-Tóth, Z;Fadgyas-Freyler, P;Kaló, Z
    Q1
    BMC HEALTH SERVICES RESEARCH
    2023.
    DOI:10.1186/s12913-023-09697-w (Copy DOI)
    120.
    Lessons learned from the application of the HEcoPerMed guidance to three modeling case studies
    Nagy, B;Zelei, T;Vellekoop, H;Huygens, S;Versteegh, M;Moelken, MRV;Koleva-Kolarova, R;Tsiachristas, A;Wordsworth, S;Szilberhorn, L
    Q3
    PERSONALIZED MEDICINE
    2023.
    DOI:10.2217/pme-2023-0040 (Copy DOI)
    121.
    A roadmap towards implementing health technology assessment in Oman
    Al Rashdi, I;Al Balushi, S;Al Shuaili, A;Al Rashdi, S;Al Bulushi, NI;Al Kindi, AI;Al Salmi, Q;Al Sabti, H;Korra, N;Abaza, S;Fasseeh, AN;Kaló, Z
    Q2
    JOURNAL OF HEALTH ORGANIZATION AND MANAGEMENT
    2024.
    DOI:10.1108/JHOM-01-2024-0012 (Copy DOI)
    122.
    Roadmap to improve the organized cancer screening programs - The case of colorectal cancer screening in Montenegro
    Kovacevic, IN;Vujovic, A;Stanisic, M;Vukovic-Lekovic, J;Lansdorp-Vogelaar, I;Mlakar, DN;Senore, C;Józwiak-Hagymásy, J;Széles, G;Vokó, Z;Csanádi, M
    Q2
    JOURNAL OF CANCER POLICY
    2024.
    DOI:10.1016/j.jcpo.2023.100464 (Copy DOI)
    123.
    The influence of institutional characteristics on implementing school-based universal addiction prevention: a Hungarian mixed-methods nationwide study on the state of implementation, barriers, and facilitators
    Arva, D;Voko, Z;Sápi, M;Cselkó, Z;Rákosy, Z
    Q2
    FRONTIERS IN EDUCATION
    2024.
    DOI:10.3389/feduc.2023.1240909 (Copy DOI)
    124.
    Prevalence and determinants of diagnosed and undiagnosed diabetes in Hungary based on the nationally representative cross-sectional H-UNCOVER study
    Fazekas-Pongor, V;Domján, BA;Major, D;Péterfi, A;Horváth, VJ;Mészáros, S;Vokó, Z;Vásárhelyi, B;Szabó, A;Burián, K;Merkely, B;Tabák, AG
    Q1
    DIABETES RESEARCH AND CLINICAL PRACTICE
    2024.
    DOI:10.1016/j.diabres.2024.111834 (Copy DOI)
    125.
    We need better ways to help students avoid the harms of stress: Results of a meta-analysis on the effectiveness of school-based stress management interventions
    Juhász, A;Sebestyén, N;Arva, D;Barta, V;Pártos, K;Vokó, Z;Rákosy, Z
    D1
    JOURNAL OF SCHOOL PSYCHOLOGY
    2024.
    DOI:10.1016/j.jsp.2024.101352 (Copy DOI)
    126.
    Tradeoffs When Building and Running Cohort and Patient-Level Markov Simulation Models
    Nagy, B;Fasseeh, AN;Campbell, JD;Kaló, Z;El-Fass, KA;Hren, R;Németh, B
    Q2
    ALGORITHMS
    2024.
    DOI:10.3390/a17120546 (Copy DOI)
    127.
    Value based healthcare and Health Technology Assessment for emerging market countries: joint efforts to overcome barriers
    Otte, M;Dauben, HP;Ahn, J;Ibarluzea, IG;Drummond, M;Simoens, S;Kalo, Z;Suh, DC
    Q2
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
    2024.
    DOI:10.1080/14737167.2024.2398482 (Copy DOI)
    128.
    Consensus-Based Recommendations for the Implementation of Health Technology Assessment in the United Arab Emirates
    Alnaqbi, KA;Elshamy, AM;Gebran, N;Fahmy, S;Aldallal, S;Korra, N;Fasseeh, AN;Kaló, Z
    Q1
    VALUE IN HEALTH REGIONAL ISSUES
    2024.
    DOI:10.1016/j.vhri.2024.101012 (Copy DOI)
    129.
    Thresholds for the value judgement of health technologies in the United Arab Emirates: a consensus approach through voting sessions
    Aldallal, S;Farghaly, M;Fahmy, S;Alnaqbi, KA;Al Naeem, W;Alsaadi, M;Moukarzel, M;Fasseeh, AN;Korra, N;Abaza, S;Kaló, Z
    Q1
    BMJ OPEN
    2024.
    DOI:10.1136/bmjopen-2024-090344 (Copy DOI)
    130.
    Revising cancer incidence in a Central European country: a Hungarian nationwide study between 2011-2019 based on a health insurance fund database
    Kiss, Z;Szabó, TG;Polgár, C;Horváth, Z;Nagy, P;Fábián, I;Kovács, V;Surján, G;Barcza, Z;Kenessey, I;Wéber, A;Wittmann, I;Molnár, GA;Gyöngyösi, E;Benedek, A;Karamousouli, E;Abonyi-Tóth, Z;Tamás, RB;Fürtos, DV;Bogos, K;Moldvay, J;Gálffy, G;Tamási, L;Müller, V;Krasznai, ZT;Ostoros, G;Pápai-Székely, Z;Maráz, A;Géczy, GB;Hilbert, L;Berki, LT;Rokszin, G;Vokó, Z
    Q2
    FRONTIERS IN ONCOLOGY
    2024.
    DOI:10.3389/fonc.2024.1393132 (Copy DOI)
    131.
    Transferability of new methods for health technology assessment in the field of diabetes between early and late adopters' countries
    Tachkov, K;Somolinos-Simón, F;Tapia-Galisteo, J;Hernando, ME;García-Sáez, G;Dimitrova, M;Kamusheva, M;Mitkova, Z;Petyko, Z;Nemeth, B;Kalo, Z;Tesar, T;Paveliu, MS;Piniazhko, O;Lipska, I;Turcu-Stiolica, A;Savova, A;Manova, M;Hren, R;Bonca, PD;Knies, S;Stanak, M;Dolezal, T;Vitezic, D;Petrova, G
    Q3
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT
    2024.
    DOI:10.1080/13102818.2024.2371354 (Copy DOI)
    132.
    Második játszma 37. lépés és negyedik játszma 78. lépés
    Vokó, Zoltán;
    Q4
    LEGE ARTIS MEDICINAE 0866-4811 2063-4161
    2020.
    DOI:10.33616/lam.30.043 (Copy DOI)
    133.
    Understanding of the Readiness for HTA Implementation in Jordan as a Step Towards Universal Health Coverage
    Alamer, Mira; Kaló, Zoltán; Schuller, Tara; Almomani, Emad; AlQutob, Raeda;
    Q4
    JORDAN MEDICAL JOURNAL 0446-9283
    2023.
    DOI:10.35516/jmj.v57i1.1103 (Copy DOI)
    134.
    A kis dózisú komputertomográfiával történő tüdőrákszűrés hazai bevezetésének kérdései
    Nagy, Balázs; Győrbíró, Dávid; Csanádi, Marcell;
    Q4
    LEGE ARTIS MEDICINAE 0866-4811 2063-4161
    2023.
    DOI:10.33616/lam.33.0105 (Copy DOI)
    135.
    Reimbursement and payment models in Central and Eastern European as well as Middle Eastern countries: A survey of their current use and future outlook
    Callenbach, MHE;Adám, L;Vreman, RA;Németh, B;Kaló, Z;Goettsch, WG
    D1
    DRUG DISCOVERY TODAY
    2023.
    DOI:10.1016/j.drudis.2022.103433 (Copy DOI)
    136.
    Designing a Roadmap for Health Technology Assessment Implementation in Algeria
    Hedibel, M;Ghanassi, FZ;El-Fass, KA;Fasseeh, AN;Abaza, S;Kaló, Z
    CUREUS JOURNAL OF MEDICAL SCIENCE
    2024.
    DOI:10.7759/cureus.65558 (Copy DOI)
    137.
    Prospects of Food Taxes for Planetary Health: A Systematic Review of Modeling Studies
    Mészáros, A;Dósa, N;Péterfi, A;Horváth, K;Szarvas, Z;Balogh, JM;Munkácsy, B;Vokó, Z
    D1
    NUTRITION REVIEWS
    2024.
    DOI:10.1093/nutrit/nuae111 (Copy DOI)
    138.
    Importance of aligning the implementation of new payment models for innovative pharmaceuticals in European countries
    Kaló, Z;Niewada, M;Bereczky, T;Goettsch, W;Vreman, RA;Xoxi, E;Trusheim, M;Callenbach, MHE;Nagy, L;Simoens, S
    Q2
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
    2024.
    DOI:10.1080/14737167.2023.2282680 (Copy DOI)
    139.
    Development of the Emirates Multi-Criteria Decision Analysis Tool for Orphan Drugs
    Alnaqbi, KA;Elezbawy, B;Fasseeh, AN;Bangash, AR;Elshamy, A;Shendi, H;Aftab, MI;Almarshoodi, M;Gebran, N;Aldhaheri, N;Fahmy, SA;Al Dallal, S;Al Naeem, W;Abaza, S;Kaló, Z
    CUREUS JOURNAL OF MEDICAL SCIENCE
    2024.
    DOI:10.7759/cureus.55215 (Copy DOI)

    Navigation

    Main page

    Publication search

    Department ranking

    Author ranking

    Author search

    Articles recently published in SJR D1 journals

    Top papers of the university

    Top field weighted citation impact publications

    Highly Cited Articles of Semmelweis University

    Semmelweis Publications
    Release: 2025_2
    Department data last refreshed at: 04.02.2025
    Author data last refreshed at: 04.02.2025
    (c) Semmelweis University - Central Library